Berkshire Hathaway to acquire Occidental's OxyChem for $9.7 billion

Berkshire Hathaway Inc. has agreed to acquire Occidental Petroleum Corporation's chemical business, OxyChem, for $9.7 billion in an all-cash transaction, expected to close in Q4 2025. Occidental plans to allocate $6.5 billion of the proceeds towards debt reduction, aiming to bring its principal debt below $15 billion following its CrownRock acquisition. This strategic acquisition further deepens Berkshire's investment in Occidental, leveraging its strong cash position to secure a robust portfolio of operating assets.

Analysis

Berkshire Hathaway (BRK) is executing a strategic acquisition of Occidental Petroleum's (OXY) chemical division, OxyChem, for $9.7 billion in an all-cash deal slated to close in Q4 2025. This transaction is well-supported by Berkshire's formidable financial position, characterized by an Altman Z-Score of 9.0 and a low 5% debt-to-capital ratio, indicating ample capacity for such a large-scale purchase without financial strain. For Occidental, the deal is a significant deleveraging event, with the company earmarking $6.5 billion of the proceeds to reduce its principal debt below its stated $15 billion target. This move is critical for strengthening OXY's balance sheet following its recent CrownRock acquisition. The structure of the agreement, where an OXY subsidiary retains legacy environmental liabilities, effectively insulates Berkshire from historical risks associated with OxyChem. This transaction deepens the existing relationship between the two firms and allows BRK to acquire a stable portfolio of cash-generating assets in the commodity chemicals space, consistent with its strategy of deploying capital into undervalued businesses, as it currently trades below its fair value with a 6% return on invested capital.

Key Decisions for Investors

• For Berkshire Hathaway investors, this acquisition reinforces the thesis of management effectively deploying its vast cash reserves into a productive, cash-flow-positive asset, which should be viewed as a constructive long-term use of capital.
• For Occidental Petroleum investors, the sale is a significant positive catalyst that materially de-risks the balance sheet by accelerating its deleveraging plan, potentially leading to a credit profile upgrade and increased financial flexibility to focus on its core oil and gas business.
• Investors in both companies should monitor the regulatory approval process, as any significant hurdles could delay the Q4 2025 closing and impact the timing of OXY's debt reduction and BRK's asset integration.